Xiong Zizhong, Zhu Demei, Wang Fu, Zhang Yingyuan, Okamoto Ryoichi, Inoue Matsuhisa
Institute of Antibiotics, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai 200040, China.
Int J Antimicrob Agents. 2004 Mar;23(3):262-7. doi: 10.1016/j.ijantimicag.2003.07.011.
A Klebsiella pneumoniae strain was isolated from a sputum specimen of a patient in the intensive care unit in 1999 in Shanghai Huashan Hospital, China. The isolate was confirmed as an extended-spectrum beta-lactamase (ESBL) producing strain by double-disk synergy test. The results of susceptibility test showed that it was resistant to most beta-lactams (including third generation cephalosporins) and non-beta-lactam antimicrobial agents. Transconjugants were obtained at a frequency of 10(-4). A plasmid of about 60 kb was obtained from the transconjugant by plasmid extraction. Three major nitrocefin-hydrolysing bands with pIs of 5.4, 8.2 and 8.4, were shown in extracts of the transconjugant. Partial gene amplification products of bla(TEM), bla(SHV), and CTX-M-1 group gene were obtained from the isolate as well as its transconjugant. The entire bla(TEM), bla(SHV), and bla(CTX-M) in the transconjugant were amplified by PCR and the PCR products were cloned into a pHSG398 vector. Afterwards, the susceptibility of transformants and activities of beta-lactamases of transformants on antibiotics were tested. The PCR products were directly sequenced, analysed and identified as TEM-1, SHV-12, and CTX-M-3 genes. These results confirm that this strain of Klebsiella pneumoniae produces SHV-12, CTX-M-3 ESBLs and TEM-1 beta-lactamase, encoded by one single plasmid, which is responsible for the resistance of this strain to most beta-lactams.
1999年,在中国上海华山医院重症监护病房的一名患者痰液标本中分离出一株肺炎克雷伯菌。通过双纸片协同试验确认该分离株为产超广谱β-内酰胺酶(ESBL)菌株。药敏试验结果表明,它对大多数β-内酰胺类药物(包括第三代头孢菌素)和非β-内酰胺类抗菌药物耐药。以10(-4)的频率获得了接合子。通过质粒提取从接合子中获得了一个约60 kb的质粒。在接合子提取物中显示出三条主要的硝基头孢菌素水解带,其pI分别为5.4、8.2和8.4。从该分离株及其接合子中获得了bla(TEM)、bla(SHV)和CTX-M-1组基因的部分基因扩增产物。通过PCR扩增了接合子中的整个bla(TEM)、bla(SHV)和bla(CTX-M),并将PCR产物克隆到pHSG398载体中。之后,测试了转化子的药敏性和转化子β-内酰胺酶对抗生素的活性。对PCR产物进行直接测序、分析,鉴定为TEM-1、SHV-12和CTX-M-3基因。这些结果证实,该肺炎克雷伯菌菌株产生由单个质粒编码的SHV-12、CTX-M-3 ESBLs和TEM-1β-内酰胺酶,这是该菌株对大多数β-内酰胺类药物耐药的原因。